Delvin W., 8

Delvin, the fourth child in a family of eight, was left in the care of his maternal grandfather after his parents separated and abandoned them. His grandfather, frail and unable to work due to old age, now bears the overwhelming responsibility of raising a total of 12 grandchildren in a single, small, grass-thatched room that offers little protection from cold and rain. With no steady income, he relies entirely on the generosity of well-wishers to provide food and clothing. Life is a daily struggle, and Delvin grows up amid poverty, where even basic necessities are uncertain. Delvin is a known sickle cell disease patient. He was brought to the hospital by his mother, presenting with severe leg pain, especially in the ankle joints, chest pain, a three-day history of cough, high fever, and difficulty breathing. After thorough examination and investigations, he was diagnosed with acute chest syndrome/vaso-occlusive crisis in sickle cell disease with anemia. He was admitted for treatment and further management.

Delvin, a known patient with sickle cell disease, was brought to the facility by his mother with severe leg pain - particularly around the ankle joints - alongside chest pain, a three-day history of cough, fever, and difficulty breathing. On assessment, he was diagnosed with acute chest syndrome and a vaso-occlusive crisis associated with sickle cell disease and anemia. He received intramuscular tramadol, intravenous ceftriaxone, oral hydroxyurea, and oral proguanil. He responded well to treatment and was later discharged in stable condition. A follow up phone call confirmed that he is doing well

Delvin’s prognosis is guarded but hopeful. With prompt and appropriate medical management for acute chest syndrome and vaso-occlusive crisis associated with sickle cell disease, his symptoms can be effectively controlled. Close monitoring, adherence to treatment, pain management, hydration, and follow-up care are essential to prevent complications. With consistent medical support and proper care, Delvin is expected to stabilize and recover, though ongoing management of his sickle cell disease will be required to reduce the risk of future crises.